Cigna(DE:CGN)
€268.20+2.20 (+0.83%)
DE:CGN
Cigna stock forecast
€268.20
At close:+2.20 (+0.83%)
Cigna (CGN) Stock Forecast & Price Target
10 Followers
CGN Analyst Ratings
Moderate Buy
10Buy5Hold0Sell
Based on 15 analysts giving stock ratings to Cigna in the past 3 months
CGN Stock 12 Month Forecast
Average Price Target
€307.64▲(14.70% Upside)Based on 15 Wall Street analysts offering 12 month price targets for Cigna in the last 3 months. The average price target is EUR 307.64 with a high forecast of EUR 352.53 and a low forecast of EUR 262.14. The average price target represents a 14.70% change from the last price of EUR 268.20.
Past 12 Months12 Month ForecastJan2026Oct2026
High€352.53
Average€307.64
Low€262.14
Highest Price TargetHighest€352.53Average Price Target€307.64Lowest Price TargetLowest€262.14
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Stephen Baxter | Wells Fargo | €277.51→€293.78 | hold | 9.54%Upside | Reiterated | 11/13/26 | ||
| Jessica Tassan | Piper Sandler | €334.45→€325.41 | buy | 21.33%Upside | Reiterated | 11/12/26 | ||
| David Windley | Jefferies | €260.33→€274.79 | hold | 2.46%Upside | Reiterated | 11/12/26 | ||
| Lance Wilkes | Bernstein | €349.82→€352.53 | buy | 31.44%Upside | Reiterated | 11/11/26 | ||
| Andrew Mok CFA | Barclays | €280.22→€289.26 | hold | 7.85%Upside | Reiterated | 11/09/26 | ||
| Michael Wiederhorn | Oppenheimer | €329.93 | buy | 23.02%Upside | Reiterated | 11/06/26 | ||
| David S Macdonald | Truist Financial | €316.38 | buy | 17.96%Upside | Reiterated | 11/06/26 | ||
| Erin Wright | Morgan Stanley | €326.32 | buy | 21.67%Upside | Assigned | 11/06/26 | ||
| Elizabeth Anderson CFA | Evercore ISI | €262.14 | hold | -2.26%Downside | Reiterated | 11/05/26 | ||
| Kevin Fischbeck | Bank of America Securities | €341.69 | buy | 27.40%Upside | Reiterated | 11/05/26 | ||
| Jason Cassorla | Guggenheim | €326.32→€313.66 | buy | 16.95%Upside | Reiterated | 11/05/26 | ||
| Sarah James | Cantor Fitzgerald | €307.34 | buy | 14.59%Upside | Reiterated | 11/05/26 | ||
| Ben Hendrix | RBC Capital | €304.62 | buy | 13.58%Upside | Reiterated | 10/07/26 | ||
 Unknown AnalystNot Ranked | Leerink Partners | €271.18 | hold | 1.11%Upside | Reiterated | 10/01/26 | ||
| Charles Rhyee | TD Cowen | €305.53 | buy | 13.92%Upside | Reiterated | 09/30/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Stephen BaxterWells Fargo | HoldReiterated€277.51→€293.78 | 11/13/26 | 9.54%Upside | ||
| Jessica TassanPiper Sandler | BuyReiterated€334.45→€325.41 | 11/12/26 | 21.33%Upside | ||
| David WindleyJefferies | HoldReiterated€260.33→€274.79 | 11/12/26 | 2.46%Upside | ||
| Lance WilkesBernstein | BuyReiterated€349.82→€352.53 | 11/11/26 | 31.44%Upside | ||
| Andrew Mok CFABarclays | HoldReiterated€280.22→€289.26 | 11/09/26 | 7.85%Upside | ||
| Michael WiederhornOppenheimer | BuyReiterated€329.93 | 11/06/26 | 23.02%Upside | ||
| David S MacdonaldTruist Financial | BuyReiterated€316.38 | 11/06/26 | 17.96%Upside | ||
| Erin WrightMorgan Stanley | BuyAssigned€326.32 | 11/06/26 | 21.67%Upside | ||
| Elizabeth Anderson CFAEvercore ISI | HoldReiterated€262.14 | 11/05/26 | -2.26%Downside | ||
| Kevin FischbeckBank of America Securities | BuyReiterated€341.69 | 11/05/26 | 27.40%Upside | ||
| Jason CassorlaGuggenheim | BuyReiterated€326.32→€313.66 | 11/05/26 | 16.95%Upside | ||
| Sarah JamesCantor Fitzgerald | BuyReiterated€307.34 | 11/05/26 | 14.59%Upside | ||
| Ben HendrixRBC Capital | BuyReiterated€304.62 | 10/07/26 | 13.58%Upside | ||
| Unknown AnalystLeerink PartnersNot Ranked | HoldReiterated€271.18 | 10/01/26 | 1.11%Upside | ||
| Charles RhyeeTD Cowen | BuyReiterated€305.53 | 09/30/26 | 13.92%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Cigna
3 Months
Success Rate17/27 ratings generated profit
63%
Average Return
+4.54%
Copying Ann Hynes's trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +4.54% per trade.
1 Year
Success Rate25/32 ratings generated profit
78%
Average Return
+17.23%
Copying Scott Fidel's trades and holding each position for 1 Year would result in 78.13% of your transactions generating a profit, with an average return of +17.23% per trade.
2 Years
Success Rate30/32 ratings generated profit
94%
Average Return
+24.47%
Copying Scott Fidel's trades and holding each position for 2 Years would result in 93.75% of your transactions generating a profit, with an average return of +24.47% per trade.
CGN Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 30 | 21 | 24 | 18 | 22 |
| Hold | 7 | 5 | 7 | 7 | 10 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 37 | 26 | 31 | 25 | 32 |
In the current month, CGN has received 22 Buy Ratings, 10 Hold Ratings, and 0 Sell Ratings. CGN average Analyst price target in the past 3 months is 307.64.
CGN Financial Forecast
High€6.72
Consensus€6.47
Low€6.35
CGN Earnings Forecast
Next quarter’s earnings estimate for CGN is EUR 6.47 with a range of EUR 6.35 to EUR 6.72. The previous quarter’s EPS was EUR 7.19. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
High€69.1B
Consensus€67.5B
Low€63.8B
CGN Sales Forecast
Next quarter’s sales forecast for CGN is EUR 67.50B with a range of EUR 63.83B to EUR 69.10B. The previous quarter’s sales results were EUR 66.43B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
CGN Stock Forecast FAQ
What is DE:CGN’s average 12-month price target, according to analysts?
Based on analyst ratings, Cigna’s 12-month average price target is €307.64.
What is DE:CGN’s upside potential, based on the analysts’ average price target?
Cigna has 14.70% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Cigna a Buy, Sell or Hold?
Cigna has a consensus rating of Moderate Buy, which is based on 10 buy ratings, 5 hold ratings and 0 sell ratings.
What is Cigna’s share price target?
The average share price target for Cigna is €307.64. This is based on 15 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €352.53, and the lowest forecast is €262.14. The average share price target represents a 14.70% increase from the current price of €268.2.
What do analysts say about Cigna?
Cigna’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of Cigna?
To buy shares of DE:CGN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
